Arthur C. Theodore, MD

Clinical Professor, Medicine

Arthur Theodore
72 E. Concord St Housman (R)


My expertise in presentation of scientific data, bedside education, communication and negotiation, conflict resolution, curriculum development, leading teams and meetings, solving problems, researching and presenting medical literature, quality improvement, strategic planning, delivering health care and comprehending law and ethics results from 14 years as Director of the Medical Intensive Care Unit, 38 years as an academic physician dedicated to education, research and clinical care, 6 years participation in the Ethics Committee and 10 years serving on the Massachusetts Consortium for Lung Transplantation.

Other Positions

  • Member, Pulmonary Center, Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University


  • Boston University, MD
  • Beloit College, BS


  • Published on 12/22/2016

    Tashkin DP, Volkmann ER, Tseng CH, Roth MD, Khanna D, Furst DE, Clements PJ, Theodore A, Kafaja S, Kim GH, Goldin J, Ariolla E, Elashoff RM. Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II. Chest. 2017 Apr; 151(4):813-820. PMID: 28012804.

    Read at: PubMed
  • Published on 7/25/2016

    Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016 Sep; 4(9):708-719. PMID: 27469583.

    Read at: PubMed
  • Published on 7/15/2015

    Raghu G, Rochwerg B, Zhang Y, Garcia CA, Azuma A, Behr J, Brozek JL, Collard HR, Cunningham W, Homma S, Johkoh T, Martinez FJ, Myers J, Protzko SL, Richeldi L, Rind D, Selman M, Theodore A, Wells AU, Hoogsteden H, Schünemann HJ. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med. 2015 Jul 15; 192(2):e3-19. PMID: 26177183.

    Read at: PubMed
  • Published on 1/1/2013

    Davidyock, T., Theodore AC. Scleroderma, Symptoms, Diagnosis and Treatment. (Romain De Winter, ed.). Identification and Treatment of the Pulmonary Manifestations of Systemic Sclerosis. Nova Science. 2013.

  • Published on 9/1/2012

    Theodore AC, Tseng CH, Li N, Elashoff RM, Tashkin DP. Correlation of cough with disease activity and treatment with cyclophosphamide in scleroderma interstitial lung disease: findings from the Scleroderma Lung Study. Chest. 2012 Sep; 142(3):614-21. PMID: 22156609.

    Read at: PubMed
  • Published on 1/1/2012

    Wilson, KC, Theodore, AC. The Intensive Care Unit Manual (Lanken, PN, Hanson, CW, Manaker, S, eds.). Smoke and carbon monoxide inhalation. Elsevier. St. Louis. 2012.

  • Published on 1/1/2012

    Theodore AC. Venous blood gases and other alternatives to arterial blood gases. 2012.

  • Published on 1/1/2010

    Theodore AC, Wilson KC. An unseen danger: frequency of posterior vessel wall penetration by needles during attempts to place internal jugular vein central catheters using ultrasound guidance. Crit Care Med. 2010 Jan; 38(1):345-6; author reply 346-7. PMID: 20023505.

    Read at: PubMed
  • Published on 4/1/2009

    Au K, Khanna D, Clements PJ, Furst DE, Tashkin DP. Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: lessons from clinical trials. Curr Rheumatol Rep. 2009 Apr; 11(2):111-9. PMID: 19296883.

    Read at: PubMed
  • Published on 2/1/2008

    Marshall J, Finn CA, Theodore AC. Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med. 2008 Feb; 36(2):427-33. PMID: 18091554.

    Read at: PubMed

View 34 more publications: View full profile at BUMC

View all profiles